世界の子宮がん治療薬・診断薬市場は、2023年から2030年の予測期間にわたって6％を超える健全な成長率で成長すると予想されています。子宮がんの子宮がん治療薬・診断薬とは、子宮内膜がんとしても知られる子宮がんの管理および検出に使用されるさまざまな治療法および診断方法を指します。子宮がんは、子宮の組織、主に子宮内膜と呼ばれる子宮の内壁に発生するがんの一種です。医療費の増加と子宮がん治療に関する意識の高まりにより、世界の子宮がん治療薬・診断薬市場の成長が促進されると予想されます
子宮がんの有病率の増加は、子宮がん治療薬・診断薬市場の成長を促進すると予想されます。Cancer.net が 2023 年に発表したレポートによると、2020 年には世界中で約 417,367 人が子宮がんと診断されました。また、子宮がんの 90% 以上は子宮内膜（子宮内膜）で見つかると推定されています。子宮内膜がんの発生率の増加は、主に女性の肥満の増加に起因しており、子宮がん治療薬・診断薬市場を牽引する重要な要因となっています。さらに、医薬品開発活動におけるイノベーションの増加とヘルスケア分野における技術進歩の高まりは、予想期間の市場成長にさまざまな有利な見通しをもたらしています。しかし、子宮がんの治療に関連する高額なコストと抗がん剤の臨床試験で観察された低い成功率により、2023年から2030年の予測期間を通じて市場の成長が抑制されます。
世界の子宮がん治療薬・診断薬市場調査の対象となる主要地域には、アジア太平洋、北アメリカ、ヨーロッパ、ラテンアメリカ、中東・アフリカが含まれます。北アメリカは、ブランド製品の優位性と同地域での病気の蔓延の増加により、2022年の市場を支配しました。子宮がんの発生率の増加と一般人口の意識の高まりが、この地域の市場の成長を推進する重要な要因です。米国癌協会によると、2020 年にアメリカで子宮体癌の新規症例は約 65,620 人と推定されています。予測期間中にアジア太平洋地域が最も高い CAGR で成長すると予想されています。診断における急速な技術進歩や新技術の急速な導入などの要因が、地域市場の成長を規定しています
この調査の目的は、近年のさまざまなセグメントおよび国の市場規模を定義し、今後数年間の市場規模を予測することです。この報告書は、調査に参加している国の業界の定性的および定量的側面の両方を組み込むように設計されています。
このレポートは、市場の将来の成長を定義する推進要因や課題などの重要な側面に関する詳細情報も提供します。さらに、競争環境と主要企業の製品提供の詳細な分析とともに、利害関係者が投資できるミクロ市場における潜在的な機会も組み込まれています。
目次
Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Uterine Cancer Therapeutics & Diagnostics Market, by Region, 2020-2030 (USD Billion)
1.2.2. Uterine Cancer Therapeutics & Diagnostics Market, by Type of Cancer, 2020-2030 (USD Billion)
1.2.3. Uterine Cancer Therapeutics & Diagnostics Market, by Product, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Uterine Cancer Therapeutics & Diagnostics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Uterine Cancer Therapeutics & Diagnostics Market Dynamics
3.1. Uterine Cancer Therapeutics & Diagnostics Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing healthcare expenditure
3.1.1.2. Growing awareness of uterine cancer
3.1.2. Market Challenges
3.1.2.1. High Cost of Uterine Cancer Therapeutics & Diagnostics
3.1.2.2. Low success rate observed in clinical trials for cancer drugs
3.1.3. Market Opportunities
3.1.3.1. Advancements in Formulation of drug development
3.1.3.2. Increasing technological advancements
Chapter 4. Global Uterine Cancer Therapeutics & Diagnostics Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Uterine Cancer Therapeutics & Diagnostics Market, by Type of Cancer
5.1. Market Snapshot
5.2. Global Uterine Cancer Therapeutics & Diagnostics Market by Type of Cancer, Performance - Potential Analysis
5.3. Global Uterine Cancer Therapeutics & Diagnostics Market Estimates & Forecasts by Type of Cancer 2020-2030 (USD Billion)
5.4. Uterine Cancer Therapeutics & Diagnostics Market, Sub Segment Analysis
5.4.1. Endometrial Adenocarcinoma
5.4.2. Adenosquamous Carcinoma
5.4.3. Papillary Serous Carcinoma
5.4.4. Uterine Sarcoma
Chapter 6. Global Uterine Cancer Therapeutics & Diagnostics Market, by Product
6.1. Market Snapshot
6.2. Global Uterine Cancer Therapeutics & Diagnostics Market by Product, Performance - Potential Analysis
6.3. Global Uterine Cancer Therapeutics & Diagnostics Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
6.4. Uterine Cancer Therapeutics & Diagnostics Market, Sub Segment Analysis
6.4.1. Therapeutics
6.4.2. Diagnostics
Chapter 7. Global Uterine Cancer Therapeutics & Diagnostics Market, Regional Analysis
7.1. Top Leading Countries
7.2. Top Emerging Countries
7.3. Uterine Cancer Therapeutics & Diagnostics Market, Regional Market Snapshot
7.4. North America Uterine Cancer Therapeutics & Diagnostics Market
7.4.1. U.S. Uterine Cancer Therapeutics & Diagnostics Market
7.4.1.1. Type of Cancer breakdown estimates & forecasts, 2020-2030
7.4.1.2. Product breakdown estimates & forecasts, 2020-2030
7.4.2. Canada Uterine Cancer Therapeutics & Diagnostics Market
7.5. Europe Uterine Cancer Therapeutics & Diagnostics Market Snapshot
7.5.1. U.K. Uterine Cancer Therapeutics & Diagnostics Market
7.5.2. Germany Uterine Cancer Therapeutics & Diagnostics Market
7.5.3. France Uterine Cancer Therapeutics & Diagnostics Market
7.5.4. Spain Uterine Cancer Therapeutics & Diagnostics Market
7.5.5. Italy Uterine Cancer Therapeutics & Diagnostics Market
7.5.6. Rest of Europe Uterine Cancer Therapeutics & Diagnostics Market
7.6. Asia-Pacific Uterine Cancer Therapeutics & Diagnostics Market Snapshot
7.6.1. China Uterine Cancer Therapeutics & Diagnostics Market
7.6.2. India Uterine Cancer Therapeutics & Diagnostics Market
7.6.3. Japan Uterine Cancer Therapeutics & Diagnostics Market
7.6.4. Australia Uterine Cancer Therapeutics & Diagnostics Market
7.6.5. South Korea Uterine Cancer Therapeutics & Diagnostics Market
7.6.6. Rest of Asia Pacific Uterine Cancer Therapeutics & Diagnostics Market
7.7. Latin America Uterine Cancer Therapeutics & Diagnostics Market Snapshot
7.7.1. Brazil Uterine Cancer Therapeutics & Diagnostics Market
7.7.2. Mexico Uterine Cancer Therapeutics & Diagnostics Market
7.8. Middle East & Africa Uterine Cancer Therapeutics & Diagnostics Market
7.8.1. Saudi Arabia Uterine Cancer Therapeutics & Diagnostics Market
7.8.2. South Africa Uterine Cancer Therapeutics & Diagnostics Market
7.8.3. Rest of Middle East & Africa Uterine Cancer Therapeutics & Diagnostics Market
Chapter 8. Competitive Intelligence
8.1. Key Company SWOT Analysis
8.1.1. Company 1
8.1.2. Company 2
8.1.3. Company 3
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. AbbVie Inc.
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Recent Developments
8.3.2. Ability Pharma SA
8.3.3. AstraZeneca PLC
8.3.4. BioMerieux S.A.
8.3.5. Danaher Corporation
8.3.6. Eli Lilly and Company
8.3.7. F. Hoffmann-La Roche Ltd
8.3.8. GlaxoSmithKline PLC
8.3.9. Johnson & Johnson Services, Inc.
8.3.10. Merck & Co., Inc
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption
List of Tables
TABLE 1. Global Uterine Cancer Therapeutics & Diagnostics Market, report scope
TABLE 2. Global Uterine Cancer Therapeutics & Diagnostics Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Uterine Cancer Therapeutics & Diagnostics Market estimates & forecasts by Type of Cancer 2020-2030 (USD Billion)
TABLE 4. Global Uterine Cancer Therapeutics & Diagnostics Market estimates & forecasts by Product 2020-2030 (USD Billion)
TABLE 5. Global Uterine Cancer Therapeutics & Diagnostics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 6. Global Uterine Cancer Therapeutics & Diagnostics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 7. Global Uterine Cancer Therapeutics & Diagnostics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Uterine Cancer Therapeutics & Diagnostics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Uterine Cancer Therapeutics & Diagnostics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Uterine Cancer Therapeutics & Diagnostics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Uterine Cancer Therapeutics & Diagnostics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Uterine Cancer Therapeutics & Diagnostics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Uterine Cancer Therapeutics & Diagnostics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Uterine Cancer Therapeutics & Diagnostics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. U.S. Uterine Cancer Therapeutics & Diagnostics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. U.S. Uterine Cancer Therapeutics & Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 17. U.S. Uterine Cancer Therapeutics & Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 18. Canada Uterine Cancer Therapeutics & Diagnostics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 19. Canada Uterine Cancer Therapeutics & Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 20. Canada Uterine Cancer Therapeutics & Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21. UK Uterine Cancer Therapeutics & Diagnostics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 22. UK Uterine Cancer Therapeutics & Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 23. UK Uterine Cancer Therapeutics & Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24. Germany Uterine Cancer Therapeutics & Diagnostics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 25. Germany Uterine Cancer Therapeutics & Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 26. Germany Uterine Cancer Therapeutics & Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27. France Uterine Cancer Therapeutics & Diagnostics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 28. France Uterine Cancer Therapeutics & Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 29. France Uterine Cancer Therapeutics & Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30. Italy Uterine Cancer Therapeutics & Diagnostics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 31. Italy Uterine Cancer Therapeutics & Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 32. Italy Uterine Cancer Therapeutics & Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33. Spain Uterine Cancer Therapeutics & Diagnostics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 34. Spain Uterine Cancer Therapeutics & Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 35. Spain Uterine Cancer Therapeutics & Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36. RoE Uterine Cancer Therapeutics & Diagnostics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 37. RoE Uterine Cancer Therapeutics & Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 38. RoE Uterine Cancer Therapeutics & Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39. China Uterine Cancer Therapeutics & Diagnostics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 40. China Uterine Cancer Therapeutics & Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 41. China Uterine Cancer Therapeutics & Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42. India Uterine Cancer Therapeutics & Diagnostics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 43. India Uterine Cancer Therapeutics & Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 44. India Uterine Cancer Therapeutics & Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45. Japan Uterine Cancer Therapeutics & Diagnostics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 46. Japan Uterine Cancer Therapeutics & Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 47. Japan Uterine Cancer Therapeutics & Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48. South Korea Uterine Cancer Therapeutics & Diagnostics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 49. South Korea Uterine Cancer Therapeutics & Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 50. South Korea Uterine Cancer Therapeutics & Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51. Australia Uterine Cancer Therapeutics & Diagnostics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 52. Australia Uterine Cancer Therapeutics & Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 53. Australia Uterine Cancer Therapeutics & Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54. RoAPAC Uterine Cancer Therapeutics & Diagnostics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 55. RoAPAC Uterine Cancer Therapeutics & Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 56. RoAPAC Uterine Cancer Therapeutics & Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57. Brazil Uterine Cancer Therapeutics & Diagnostics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 58. Brazil Uterine Cancer Therapeutics & Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 59. Brazil Uterine Cancer Therapeutics & Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60. Mexico Uterine Cancer Therapeutics & Diagnostics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 61. Mexico Uterine Cancer Therapeutics & Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 62. Mexico Uterine Cancer Therapeutics & Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63. RoLA Uterine Cancer Therapeutics & Diagnostics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 64. RoLA Uterine Cancer Therapeutics & Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 65. RoLA Uterine Cancer Therapeutics & Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66. Saudi Arabia Uterine Cancer Therapeutics & Diagnostics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 67. South Africa Uterine Cancer Therapeutics & Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 68. RoMEA Uterine Cancer Therapeutics & Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69. List of secondary sources, used in the study of global Uterine Cancer Therapeutics & Diagnostics Market
TABLE 70. List of primary sources, used in the study of global Uterine Cancer Therapeutics & Diagnostics Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered
List of tables and figures are dummy in nature, final lists may vary in the final deliverable
List of figures
FIG 1. Global Uterine Cancer Therapeutics & Diagnostics Market, research methodology
FIG 2. Global Uterine Cancer Therapeutics & Diagnostics Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Uterine Cancer Therapeutics & Diagnostics Market, key trends 2022
FIG 5. Global Uterine Cancer Therapeutics & Diagnostics Market, growth prospects 2023-2030
FIG 6. Global Uterine Cancer Therapeutics & Diagnostics Market, porters 5 force model
FIG 7. Global Uterine Cancer Therapeutics & Diagnostics Market, pest analysis
FIG 8. Global Uterine Cancer Therapeutics & Diagnostics Market, value chain analysis
FIG 9. Global Uterine Cancer Therapeutics & Diagnostics Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Uterine Cancer Therapeutics & Diagnostics Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Uterine Cancer Therapeutics & Diagnostics Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Uterine Cancer Therapeutics & Diagnostics Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Uterine Cancer Therapeutics & Diagnostics Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Uterine Cancer Therapeutics & Diagnostics Market, regional snapshot 2020 & 2030
FIG 15. North America Uterine Cancer Therapeutics & Diagnostics Market 2020 & 2030 (USD Billion)
FIG 16. Europe Uterine Cancer Therapeutics & Diagnostics Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific Uterine Cancer Therapeutics & Diagnostics Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Uterine Cancer Therapeutics & Diagnostics Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Uterine Cancer Therapeutics & Diagnostics Market 2020 & 2030 (USD Billion)
List of tables and figures are dummy in nature, final lists may vary in the final deliverable
